Journal profile · PHARMACOLOGY & PHARMACY
European Journal of Hospital Pharmacy
ISSN 2047-9956 · eISSN 2047-9964 · BMJ PUBLISHING GROUP · ENGLAND
European Journal of Hospital Pharmacy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.44; hybrid open access; median 116 days to acceptance (72 articles, last 24 months); 120 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Hospital Pharmacy is published by BMJ PUBLISHING GROUP and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices and Safe Handling of Antineoplastic Drugs, together about 41.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Phil WiffenPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 2, Sweden 1, Norway 1, Austria 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine21.5%
- Pharmaceutical studies and practicesMedicine12.6%
- Safe Handling of Antineoplastic DrugsHealth Professions7.5%
- Patient Safety and Medication ErrorsHealth Professions6.9%
- Medication Adherence and ComplianceMedicine5.4%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.9%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics4.8%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCINAHLPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.44LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- CiteScore (publisher)
- 3.5Publisher website ·
- SJR 2026-06
- 0.44LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 41OpenAlex ·
- i10-index
- 367OpenAlex ·
- 2-year mean citedness
- 1.15OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 14.96%LetPub ·
Volume
- Articles per year
- 82LetPub ·
Articles by year OpenAlex count · 3,416 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 91 | 14 | 20 |
| 2025 | 120 | 34 | 110 |
| 2024 | 107 | 29 | 236 |
| 2023 | 111 | 70 | 437 |
| 2022 | 117 | 117 | 590 |
| 2021 | 167 | 159 | 1,104 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
116 daysMedian, submission to acceptance · P25–P75 94 days – 169 days
- Acceptance to online
- median 268 days (72 articles)
- Submission to online
- median 372 days
- Sample
- 72 articles with submission and acceptance dates (337 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- case reportsInteresting case reports and medicines information queries are also welcomed.Length not stated
- medicines information queriesInteresting case reports and medicines information queries are also welcomed.Length not stated
- original articlesEuropean Journal of Hospital Pharmacy considers unsolicited submissions of a wide range of article types, including original articles, systematic reviews and sh…Length not stated
- short reportsEuropean Journal of Hospital Pharmacy considers unsolicited submissions of a wide range of article types, including original articles, systematic reviews and sh…Length not stated
- systematic reviewsEuropean Journal of Hospital Pharmacy considers unsolicited submissions of a wide range of article types, including original articles, systematic reviews and sh…Length not stated
Policy excerpts from the journal's websitePublication ethics, Open access
- Publication ethics
Publication ethics standards Model summary
European Journal of Hospital Pharmacy adheres to the highest possible industry standards concerning publication ethics.
Source ↗Publisher website ·- Open access Open Access
Original research:Education and research practices in Irish hospital pharmacies: a national service evaluation by the Hospital Pharmacists Association of Ireland Specialist Interest Group on Education and Research10 July 2026Original research:Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital12 May 2026Original re…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMJ PUBLISHING GROUP
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2047-9956
- Electronic ISSN
- 2047-9964
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Hospital Pharmacy
What CAS zone is European Journal of Hospital Pharmacy in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Hospital Pharmacy is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Hospital Pharmacy?
The latest impact factor listed by LetPub is 1.44; CiteScore 3.5, h-index 41.
How long does peer review take at European Journal of Hospital Pharmacy?
Based on the dates recorded on 72 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 116 days (interquartile range 94–169 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Journal of Hospital Pharmacy based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (2), Sweden (1) and Norway (1). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Hospital Pharmacy?
According to LetPub and DOAJ records, European Journal of Hospital Pharmacy is indexed in SCIE and Scopus. The journal's website also lists Embase and CINAHL; that list has not been checked against each database.
Is European Journal of Hospital Pharmacy open access, and what is the APC?
European Journal of Hospital Pharmacy is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .